ConductScience.org, home

Paper41399367

Role of Circular RNAs in Liver Diseases.

Alzahrani B. Int J Med Sci, 2026. Cited by 3 papers, by iCite.

Cite this record

ConductScience Library. Role of Circular RNAs in Liver Diseases. Papers, record 41399367. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41399367

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Role of Circular RNAs in Liver Diseases.
PubMed
Journal
Int J Med Sci
PubMed
Year
2026
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
3
iCite
Revised in PubMed
2026-01-02
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Alzahrani BBadr

Source PubMed

Download CSV of authors

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
RNA, CircularMajor topic
Liver DiseasesMajor topic
Humans
Liver
MicroRNAs
Biomarkers
Liver Neoplasms
Gene Expression Regulation
Signal Transduction

Source PubMed

Download CSV of topics

References103

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
129018509circRNA_0046367 Prevents Hepatoxicity of Lipid Peroxidation: An Inhibitory Role against Hepatic Steatosis.Oxid Med Cell Longev2017https://conductscience.org/library/papers/29018509PubMed
236186461Profile analysis and functional modeling identify circular RNAs in nonalcoholic fatty liver disease as regulators of hepatic lipid metabolism.Front Genet2022https://conductscience.org/library/papers/36186461PubMed
332532962Circular RNA circZNF566 promotes hepatocellular carcinoma progression by sponging miR-4738-3p and regulating TDO2 expression.Cell Death Dis2020https://conductscience.org/library/papers/32532962PubMed
433364841CircPVT1 Regulates Cell Proliferation, Apoptosis and Glycolysis in Hepatocellular Carcinoma via miR-377/TRIM23 Axis.Cancer Manag Res2020https://conductscience.org/library/papers/33364841PubMed
532943922Exosomal Circ-ZNF652 Promotes Cell Proliferation, Migration, Invasion and Glycolysis in Hepatocellular Carcinoma via miR-29a-3p/GUCD1 Axis.Cancer Manag Res2020https://conductscience.org/library/papers/32943922PubMed
632077624hsa_circ_0000092 promotes hepatocellular carcinoma progression through up-regulating HN1 expression by binding to microRNA-338-3p.J Cell Mol Med2024https://conductscience.org/library/papers/32077624PubMed
728727484Construction and analysis of circular RNA molecular regulatory networks in liver cancer.Cell Cycle2017https://conductscience.org/library/papers/28727484PubMed
830053867circFBLIM1 act as a ceRNA to promote hepatocellular cancer progression by sponging miR-346.J Exp Clin Cancer Res2018https://conductscience.org/library/papers/30053867PubMed
933982351Circular RNA circUbe2k promotes hepatic fibrosis via sponging miR-149-5p/TGF-β2 axis.FASEB J2021https://conductscience.org/library/papers/33982351PubMed
1031148365CircMTO1 inhibits liver fibrosis via regulation of miR-17-5p and Smad7.J Cell Mol Med2019https://conductscience.org/library/papers/31148365PubMed
1132037619Circ-HOMER1 enhances the inhibition of miR-1322 on CXCL6 to regulate the growth and aggressiveness of hepatocellular carcinoma cells.J Cell Biochem2020https://conductscience.org/library/papers/32037619PubMed
1228717649Circular RNA Profiling and Bioinformatic Modeling Identify Its Regulatory Role in Hepatic Steatosis.Biomed Res Int2017https://conductscience.org/library/papers/28717649PubMed
1331841181Circ_0091579 promotes proliferative ability and metastasis of liver cancer cells by regulating microRNA-490-3p.Eur Rev Med Pharmacol Sci2019https://conductscience.org/library/papers/31841181PubMed
1435584701Circular RNAs: Characterization, cellular roles, and applications.Cell2022https://conductscience.org/library/papers/35584701PubMed
1529251325CD90 promotes cell migration, viability and sphere‑forming ability of hepatocellular carcinoma cells.Int J Mol Med2018https://conductscience.org/library/papers/29251325PubMed
1626600397Hsa_circ_0001649: A circular RNA and potential novel biomarker for hepatocellular carcinoma.Cancer Biomark2016https://conductscience.org/library/papers/26600397PubMed
1736979495LncRNA and circRNA in Patients with Non-Alcoholic Fatty Liver Disease: A Systematic Review.Biomolecules2023https://conductscience.org/library/papers/36979495PubMed
1829458020CircRNA circ_0067934 promotes tumor growth and metastasis in hepatocellular carcinoma through regulation of miR-1324/FZD5/Wnt/β-catenin axis.Biochem Biophys Res Commun2018https://conductscience.org/library/papers/29458020PubMed
1931695501Silencing Of hsa_circ_0008450 Represses Hepatocellular Carcinoma Progression Through Regulation Of microRNA-214-3p/EZH2 Axis.Cancer Manag Res2019https://conductscience.org/library/papers/31695501PubMed
2032054840Antagonizing circRNA_002581-miR-122-CPEB1 axis alleviates NASH through restoring PTEN-AMPK-mTOR pathway regulated autophagy.Cell Death Dis2020https://conductscience.org/library/papers/32054840PubMed

See all 103 referencesDownload CSV of references

Cited by4

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.

PMIDTitleJournalYearIn PapersSource
42947178Targeting circular RNAs to overcome therapeutic resistance in liver cancer: from mechanisms to clinical prospects.Mol Cancer2026https://conductscience.org/library/papers/42947178PubMed
42746222Target, silence, replace: a review on RNA-based drugs in modern medicine.Front Cell Dev Biol2026https://conductscience.org/library/papers/42746222PubMed
42376277CircRNAs in hepatic lipid metabolism: regulatory mechanisms and clinical implications.Front Genet2026https://conductscience.org/library/papers/42376277PubMed
42322462RNA-binding proteins in aging and age-related diseases: roles, mechanisms, and a large language model analysis.Biogerontology2026https://conductscience.org/library/papers/42322462PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41399367

GET https://conductscience.org/api/papers/v1/41399367/references?page=2